Cormorant Asset Management »

Oruka Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 533k 19.23

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
Viking Global Investors
Deep Track Capital
BlackRock
Rtw Investments
Vanguard Group
Commodore Capital
Braidwell
venBio Select Advisor
Perceptive Advisors
Franklin Resources
Point72 Asset Management
Polar Capital Holdings

View all funds holding Oruka Therapeutics